Read about the safety information of LUCENTIS
LUCENTIS® (ranibizumab injection) is a prescription medicine for the treatment of patients with wet age-related macular degeneration (wAMD), macular edema following retinal vein occlusion (RVO), and diabetic macular edema (DME).
LUCENTIS is a prescription medication given by injection into the eye, and it has side effects. Some LUCENTIS patients have had detached retinas and serious infections inside the eye. You should not use LUCENTIS if you have an infection in or around the eye or are allergic to LUCENTIS or any of its ingredients.
Uncommonly, LUCENTIS patients have had serious, sometimes fatal, problems related to blood clots, such as heart attacks or strokes.
Some patients have had increased eye pressure before and within 1 hour of an injection.
Serious side effects include inflammation inside the eye and, rarely, problems related to the injection procedure, such as cataracts. These side effects can make your vision worse.
The most common eye-related side effects are increased redness in the white of the eye, eye pain, small specks in vision, and increased eye pressure. The most common non-eye-related side effects are nose and throat infections, headache, lung/airway infections, and nausea.
If your eye becomes red, sensitive to light, or painful, or if you have a change in vision, call or visit your eye doctor right away.
For additional safety information, please talk to your doctor and see the LUCENTIS full prescribing information.
The information contained in this section of the site is intended for U.S. healthcare professionals only. Click "OK" if you are a healthcare professional.
The link you have selected will take you away from this site to one that is not owned or controlled by Genentech, Inc. Genentech, Inc. makes no representation as to the accuracy of the information contained on sites we do not own or control. Genentech, Inc. does not recommend and does not endorse the content on any third-party websites. Your use of third-party websites is at your own risk and subject to the terms and conditions of use for such sites.
Wet age-related macular degeneration(wet AMD)
Macular edema following retinal vein occlusion(RVO)
LUCENTIS has been studied for over 10 years
LUCENTIS is supported by over a decade of clinical research. Approved by the FDA in 2006, LUCENTIS has been studied in 4 key trials that included 1,873 patients with wet AMD.
9 out of 10 maintained* or improved vision
In clinical studies, 9 out of 10 people receiving LUCENTIS once a month for 2 years maintained* or improved vision.
*Defined as losing fewer than 15 letters on the eye chart.
Possible serious side effects of LUCENTIS
Some patients gained 21 letters
Two years after starting treatment, people in 2 clinical trials who received LUCENTIS once a month were able to read an average of 21 more letters on the eye chart than people who did not receive LUCENTIS.
What does seeing 21
more letters mean?
Your Retina Specialist uses an eye chart to measure your vision. The farther down the chart you can see—as the letters get smaller—the better your vision.
The chance for 20/40 vision
Up to 50% of patients maintained or improved their visual acuity to 20/40 or better after 1 year with LUCENTIS treatments.
What is 20/40 vision?
You've probably heard of 20/20 vision, which is considered normal vision. You can also see well with 20/40 vision. If you have 20/40 vision, you can typically sit near the back of a theater and see what's going on up front.
Up to 5 out of 10 patients maintained or improved their visual acuity to 20/40 or better after 1 year with LUCENTIS treatments. Individual results may vary.
LUCENTIS is a medicine that is injected by your doctor into the eye. Like all medicines, LUCENTIS has possible side effects. It is important for you to know what they are.
Talk with your eye doctor if you have:
Although it is uncommon, some people treated with LUCENTIS may have a life-threatening side effect.
Your doctor will stop treatment if any serious side effects occur. Be sure to contact your doctor if there are any signs of side effects.
Serious reactions have occurred related to the injection. They have happened in fewer than 0.1% (1 in 1,000) of people. These reactions can make your vision worse.
The retina is the light-sensitive layer of tissue that lines the inside of the eye. It sends visual messages through the optic nerve to the brain. When the retina detaches, it is lifted or pulled from its normal position.
A cataract is a clouding of the lens of the eye.
Some people have increased eye pressure before and within 1 hour after an injection. Your eye doctor should check your eyes and your eye pressure during the week after your injection.
A stroke happens when a blood vessel that carries oxygen to the brain is either blocked by a clot or bursts. This means that part of the brain cannot get the oxygen it needs. As a result, the brain gets damaged.
A heart attack happens when a blood vessel that carries oxygen to the heart is either blocked by a clot or bursts. This means that part of the heart cannot get the oxygen it needs. As a result, the heart gets damaged.
Call or visit your eye doctor right away if:
Here are the most common eye-related side effects in clinical studies of LUCENTIS:
Here are the most common non-eye-related side effects in clinical studies of LUCENTIS:
LUCENTIS is for prescription use only.